Pantothenate derivatives for the treatment of neurological disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 20, 2018
Grant Date -
Sep 15, 2016
app pub date -
Oct 27, 2014
filing date -
Oct 25, 2013
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Compounds having the following formula (E): Formula E or a pharmaceutically acceptable salt thereof, wherein R, R′, R″, X and n are as defined herein are provided. Methods comprising use of such compounds for the treatment of neurologic disorders, such as pantothenate kinase-associated neurodegeneration, and pharmaceutical compositions containing such compounds, and their use in treatment of neurologic disorders are also provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully